The Nexus of Long Noncoding RNAs, Splicing Factors, Alternative Splicing and Their Modulations

Overview

Journal RNA Biol

Specialty Molecular Biology

Date 2023 Nov 29

PMID 38017665

Authors

Pushkar Malakar

Sudhanshu Shukla

Meghna Mondal

Rajesh Kumar Kar

Jawed Akhtar Siddiqui

Affiliations

Soon will be listed here.

Abstract

The process of alternative splicing (AS) is widely deregulated in a variety of cancers. Splicing is dependent upon splicing factors. Recently, several long noncoding RNAs (lncRNAs) have been shown to regulate AS by directly/indirectly interacting with splicing factors. This review focuses on the regulation of AS by lncRNAs through their interaction with splicing factors. AS mis-regulation caused by either mutation in splicing factors or deregulated expression of splicing factors and lncRNAs has been shown to be involved in cancer development and progression, making aberrant splicing, splicing factors and lncRNA suitable targets for cancer therapy. This review also addresses some of the current approaches used to target AS, splicing factors and lncRNAs. Finally, we discuss research challenges, some of the unanswered questions in the field and provide recommendations to advance understanding of the nexus of lncRNAs, AS and splicing factors in cancer.

Citing Articles

lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer.

Bhat A, Afzal M, Moglad E, Thapa R, Ali H, Almalki W Clin Exp Med. 2024; 24(1):226.

PMID: 39325172 PMC: 11427524. DOI: 10.1007/s10238-024-01491-0.

PTBP3 Mediates IL-18 Exon Skipping to Promote Immune Escape in Gallbladder Cancer.

Zhao C, Zhao J, Zhang Y, Zhu Y, Yang Z, Liu S Adv Sci (Weinh). 2024; 11(38):e2406633.

PMID: 39116343 PMC: 11481411. DOI: 10.1002/advs.202406633.

The Many Roads from Alternative Splicing to Cancer: Molecular Mechanisms Involving Driver Genes.

Gimeno-Valiente F, Lopez-Rodas G, Castillo J, Franco L Cancers (Basel). 2024; 16(11).

PMID: 38893242 PMC: 11171328. DOI: 10.3390/cancers16112123.

Saliva, a molecular reflection of the human body? Implications for diagnosis and treatment.

Geli V, Nabet N Cell Stress. 2024; 8:59-68.

PMID: 38826491 PMC: 11144459. DOI: 10.15698/cst2024.05.297.

LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin.

Feng H, Xu D, Jiang C, Chen Y, Wang J, Ren Z Biomark Res. 2024; 12(1):19.

PMID: 38311781 PMC: 10840222. DOI: 10.1186/s40364-024-00571-3.

References

Du M, Jillette N, Zhu J, Li S, Cheng A . CRISPR artificial splicing factors. Nat Commun. 2020; 11(1):2973. PMC: 7293279. DOI: 10.1038/s41467-020-16806-4. View

Chen Y, Shen T, Ding X, Ma C, Cheng L, Sheng L . lncRNA MRUL Suppressed Non-Small Cell Lung Cancer Cells Proliferation and Invasion by Targeting miR-17-5p/SRSF2 Axis. Biomed Res Int. 2020; 2020:9567846. PMC: 7582093. DOI: 10.1155/2020/9567846. View

Chang J, Yang D, Chang W, Chow L, Chan W, Lin H . Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells. PLoS One. 2011; 6(6):e18643. PMC: 3111415. DOI: 10.1371/journal.pone.0018643. View

Hube F, Guo J, Chooniedass-Kothari S, Cooper C, Hamedani M, Dibrov A . Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA Cell Biol. 2006; 25(7):418-28. DOI: 10.1089/dna.2006.25.418. View

Mattick J, Amaral P, Carninci P, Carpenter S, Chang H, Chen L . Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023; 24(6):430-447. PMC: 10213152. DOI: 10.1038/s41580-022-00566-8. View

Rossi F, Labourier E, Forne T, Divita G, Derancourt J, Riou J . Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature. 1996; 381(6577):80-2. DOI: 10.1038/381080a0. View

Graveley B, Maniatis T . Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol Cell. 1998; 1(5):765-71. DOI: 10.1016/s1097-2765(00)80076-3. View

Shechner D, Hacisuleyman E, Younger S, Rinn J . Multiplexable, locus-specific targeting of long RNAs with CRISPR-Display. Nat Methods. 2015; 12(7):664-70. PMC: 4821475. DOI: 10.1038/nmeth.3433. View

Gagnon K, Li L, Chu Y, Janowski B, Corey D . RNAi factors are present and active in human cell nuclei. Cell Rep. 2014; 6(1):211-21. PMC: 3916906. DOI: 10.1016/j.celrep.2013.12.013. View

10.

Huot M, Vogel G, Zabarauskas A, Ngo C, Coulombe-Huntington J, Majewski J . The Sam68 STAR RNA-binding protein regulates mTOR alternative splicing during adipogenesis. Mol Cell. 2012; 46(2):187-99. DOI: 10.1016/j.molcel.2012.02.007. View

11.

Pan Q, Shai O, Lee L, Frey B, Blencowe B . Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008; 40(12):1413-5. DOI: 10.1038/ng.259. View

12.

Spiniello M, Knoener R, Steinbrink M, Yang B, Cesnik A, Buxton K . HyPR-MS for Multiplexed Discovery of MALAT1, NEAT1, and NORAD lncRNA Protein Interactomes. J Proteome Res. 2018; 17(9):3022-3038. PMC: 6425737. DOI: 10.1021/acs.jproteome.8b00189. View

13.

Mattick J, Rinn J . Discovery and annotation of long noncoding RNAs. Nat Struct Mol Biol. 2015; 22(1):5-7. DOI: 10.1038/nsmb.2942. View

14.

Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P . Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Oncogene. 1999; 18(24):3564-73. DOI: 10.1038/sj.onc.1202670. View

15.

Duan Y, Jia Y, Wang J, Liu T, Cheng Z, Sang M . Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1. Cell Death Dis. 2021; 12(6):587. PMC: 8184765. DOI: 10.1038/s41419-021-03858-7. View

16.

Aartsma-Rus A, van Ommen G . Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications. RNA. 2007; 13(10):1609-24. PMC: 1986821. DOI: 10.1261/rna.653607. View

17.

Obeng E, Chappell R, Seiler M, Chen M, Campagna D, Schmidt P . Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. Cancer Cell. 2016; 30(3):404-417. PMC: 5023069. DOI: 10.1016/j.ccell.2016.08.006. View

18.

Wang H, Fang L, Jiang J, Kuang Y, Wang B, Shang X . The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation. Cell Death Dis. 2018; 9(11):1103. PMC: 6207559. DOI: 10.1038/s41419-018-1148-y. View

19.

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

20.

Zeng Y, Yi R, Cullen B . MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A. 2003; 100(17):9779-84. PMC: 187842. DOI: 10.1073/pnas.1630797100. View